Keros Therapeutics PEG Ratio

As of the most recent data, KROS shows a PEG ratio of 46.58. That is above the Healthcare sector average of 1.26. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 1.26. Keros Therapeutics is at 46.58, which is higher that average. That is roughly 3604.7% above the sector mean. Use the comparison chart on this page to see how KROS stacks up against individual peers as well.

Investors watch KROS's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Keros Therapeutics's latest reading is 46.58. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Keros Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 46.58) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 1.26, while KROS is at 46.58. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.